164 related articles for article (PubMed ID: 10638221)
1. [Mechanisms of anti-atherogenic action of probucol].
Ohya T; Egusa G
Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
[TBL] [Abstract][Full Text] [Related]
2. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
3. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Sundell CL; Somers PK; Meng CQ; Hoong LK; Suen KL; Hill RR; Landers LK; Chapman A; Butteiger D; Jones M; Edwards D; Daugherty A; Wasserman MA; Alexander RW; Medford RM; Saxena U
J Pharmacol Exp Ther; 2003 Jun; 305(3):1116-23. PubMed ID: 12626663
[TBL] [Abstract][Full Text] [Related]
4. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
Hirano K; Ikegami C; Tsujii K; Zhang Z; Matsuura F; Nakagawa-Toyama Y; Koseki M; Masuda D; Maruyama T; Shimomura I; Ueda Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2422-7. PubMed ID: 16151015
[TBL] [Abstract][Full Text] [Related]
5. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
Sirtori CR; Franceschini G
N Engl J Med; 1997 Dec; 337(26):1918; author reply 1919. PubMed ID: 9417525
[No Abstract] [Full Text] [Related]
6. Where are we with probucol: a new life for an old drug?
Yamashita S; Matsuzawa Y
Atherosclerosis; 2009 Nov; 207(1):16-23. PubMed ID: 19457483
[TBL] [Abstract][Full Text] [Related]
7. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
[No Abstract] [Full Text] [Related]
8. AGI-1067: a novel vascular protectant for prevention of restenosis.
Franks AM; Gardner SF
Ann Pharmacother; 2006 Jan; 40(1):66-73. PubMed ID: 16303986
[TBL] [Abstract][Full Text] [Related]
9. Effect of the anti-oxidant probucol on soluble thrombomodulin (sTM) in hypercholesterolemic rabbits.
Hong SC; Zhao SP; Liu Q; Wu ZH
Int J Cardiol; 2008 Jan; 123(2):180-2. PubMed ID: 17292497
[TBL] [Abstract][Full Text] [Related]
10. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
[TBL] [Abstract][Full Text] [Related]
11. Probucol alleviates atherosclerosis and improves high density lipoprotein function.
Zhong JK; Guo ZG; Li C; Wang ZK; Lai WY; Tu Y
Lipids Health Dis; 2011 Nov; 10():210. PubMed ID: 22078494
[TBL] [Abstract][Full Text] [Related]
12. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024
[TBL] [Abstract][Full Text] [Related]
13. Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds.
Tanous D; Hime N; Stocker R
Redox Rep; 2008; 13(2):48-59. PubMed ID: 18339247
[TBL] [Abstract][Full Text] [Related]
14. Probucol as an antioxidant and antiatherogenic drug.
Kuzuya M; Kuzuya F
Free Radic Biol Med; 1993 Jan; 14(1):67-77. PubMed ID: 8454225
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoproteins are required for both basal and stress-induced adrenal glucocorticoid synthesis and protection against endotoxemia in mice.
Hoekstra M; Korporaal SJ; Li Z; Zhao Y; Van Eck M; Van Berkel TJ
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1038-43. PubMed ID: 20858753
[TBL] [Abstract][Full Text] [Related]
16. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic N; Singal PK
Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
Artery; 1995; 21(6):337-51. PubMed ID: 8833232
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol.
Shi A; Yoshinari M; Iino K; Wakisaka M; Iwase M; Fujishima M
Exp Clin Endocrinol Diabetes; 1999; 107(6):337-42. PubMed ID: 10543409
[TBL] [Abstract][Full Text] [Related]
19. [The effect of phenol antioxidants on the development of alloxan diabetes in rats].
Bobyreva LE
Eksp Klin Farmakol; 1997; 60(3):51-3. PubMed ID: 9324400
[TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
Doggrell SA
Expert Opin Investig Drugs; 2003 Nov; 12(11):1855-9. PubMed ID: 14585060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
